Shanghai Xiao Fang Pharmaceutical (603207.SH) awarded 1.28 million restricted shares to 178 incentive recipients.

Shanghai Xiao Fang Pharmaceutical (603207.SH) announced that the company's board of directors believes that the conditions for granting restricted stocks as prescribed in the company's 2025 Restricted Stock Incentive Plan have been met. The company has determined that the initial grant date for this incentive plan is February 13, 2025, and has agreed to grant 1.28 million restricted stocks to 178 incentive recipients at a price of 14.97 yuan per share.